A detailed history of Pfg Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Pfg Advisors holds 22,453 shares of PFE stock, worth $616,559. This represents 0.04% of its overall portfolio holdings.

Number of Shares
22,453
Previous 21,972 2.19%
Holding current value
$616,559
Previous $614,000 5.7%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $13,323 - $15,098
481 Added 2.19%
22,453 $649,000
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $60,725 - $71,158
-2,404 Reduced 9.86%
21,972 $614,000
Q1 2024

May 06, 2024

SELL
$25.89 - $29.73 $40,724 - $46,765
-1,573 Reduced 6.06%
24,376 $676,000
Q4 2023

Jan 19, 2024

SELL
$26.13 - $33.94 $82,204 - $106,775
-3,146 Reduced 10.81%
25,949 $747,000
Q3 2023

Oct 13, 2023

SELL
$32.09 - $37.51 $524,639 - $613,250
-16,349 Reduced 35.98%
29,095 $965,000
Q2 2023

Jul 20, 2023

SELL
$36.12 - $41.79 $52,590 - $60,846
-1,456 Reduced 3.1%
45,444 $1.67 Million
Q1 2023

Apr 20, 2023

SELL
$39.39 - $51.28 $192,065 - $250,041
-4,876 Reduced 9.42%
46,900 $1.91 Million
Q4 2022

Jan 27, 2023

BUY
$41.75 - $54.5 $205,451 - $268,194
4,921 Added 10.5%
51,776 $2.65 Million
Q3 2022

Oct 13, 2022

SELL
$43.76 - $53.42 $16,935 - $20,673
-387 Reduced 0.82%
46,855 $2.05 Million
Q2 2022

Jul 13, 2022

BUY
$46.53 - $55.17 $97,806 - $115,967
2,102 Added 4.66%
47,242 $2.48 Million
Q1 2022

Apr 19, 2022

SELL
$45.75 - $56.69 $10,751 - $13,322
-235 Reduced 0.52%
45,140 $2.34 Million
Q4 2021

Jan 21, 2022

BUY
$41.32 - $61.25 $189,204 - $280,463
4,579 Added 11.22%
45,375 $2.68 Million
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $76,027 - $97,663
-1,937 Reduced 4.53%
40,796 $1.76 Million
Q2 2021

Jul 28, 2021

BUY
$35.91 - $40.68 $73,615 - $83,394
2,050 Added 5.04%
42,733 $1.67 Million
Q1 2021

Apr 27, 2021

BUY
$33.49 - $37.77 $469,630 - $529,648
14,023 Added 52.6%
40,683 $1.47 Million
Q4 2020

Jan 26, 2021

BUY
$33.47 - $42.56 $131,001 - $166,579
3,914 Added 17.21%
26,660 $981,000
Q3 2020

Oct 13, 2020

BUY
$31.75 - $37.25 $15,049 - $17,656
474 Added 2.13%
22,746 $829,000
Q2 2020

Jul 16, 2020

SELL
$30.12 - $36.54 $62,077 - $75,308
-2,061 Reduced 8.47%
22,272 $754,000
Q1 2020

Apr 29, 2020

BUY
$27.03 - $38.62 $58,141 - $83,071
2,151 Added 9.7%
24,333 $878,000
Q4 2019

Jan 14, 2020

BUY
$32.92 - $37.36 $14,846 - $16,849
451 Added 2.08%
22,182 $866,000
Q3 2019

Oct 15, 2019

SELL
$32.49 - $42.13 $1,039 - $1,348
-32 Reduced 0.15%
21,731 $776,000
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $100,030 - $112,311
2,705 Added 14.19%
21,763 $937,000
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $438,412 - $481,669
11,691 Added 158.69%
19,058 $774,000
Q4 2018

Feb 19, 2019

SELL
$38.47 - $43.86 $75,170 - $85,702
-1,954 Reduced 20.96%
7,367 $308,000
Q4 2018

Jan 18, 2019

BUY
$38.47 - $43.86 $103,484 - $117,983
2,690 Added 40.57%
9,321 $404,000
Q3 2018

Oct 26, 2018

SELL
$34.47 - $41.81 $5,687 - $6,898
-165 Reduced 2.43%
6,631 $292,000
Q2 2018

Jul 19, 2018

BUY
$32.98 - $35.16 $9,893 - $10,547
300 Added 4.62%
6,796 $247,000
Q1 2018

Apr 06, 2018

BUY
$31.91 - $37.02 $207,287 - $240,481
6,496 New
6,496 $231,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pfg Advisors Portfolio

Follow Pfg Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Advisors with notifications on news.